Abstract
In this issue of Blood, Mossner et al took an important step in delineating the evolution of myelodysplastic syndrome (MDS). They were able to estimate mutation acquisition order and to demonstrate that, in the majority of MDS cases, earlier preexisting minor clones survived therapy.
Original language | English |
---|---|
Pages (from-to) | 1162-1163 |
Number of pages | 2 |
Journal | Blood |
Volume | 128 |
Issue number | 9 |
DOIs |
|
Publication status | Published - 1 Sept 2016 |
All Science Journal Classification (ASJC) codes
- Hematology
- Biochemistry
- Cell Biology
- Immunology